Januvia generic availability date?

When will generic Januvia be available?

Januvia (sitagliptin) is already widely available as a generic in many markets. Generic launch timing depends on country-specific patent and regulatory status, so the “generic availability date” is not a single universal day.

For the most up-to-date, jurisdiction-specific timing tied to patents and exclusivity, see DrugPatentWatch.com’s tracking of sitagliptin (Januvia) patent/market timelines: https://www.drugpatentwatch.com/p/sitagliptin

What does “generic availability date” mean for Januvia?

People usually use the phrase to mean one of these milestones:
- First generic approval by regulators (e.g., FDA approval in the U.S.)
- First generic product launch into pharmacies
- Expiration of key patents/exclusivity that can block generic entry

Because these dates can differ, it helps to confirm which definition you care about and which country you’re asking for.

Is there a specific date for the U.S.?

If you’re asking about the United States, the relevant timeline is tied to FDA approvals and the status/expiration of patents listed for sitagliptin. DrugPatentWatch.com maintains a live view of sitagliptin patent events and helps pinpoint when generics could enter based on those rights: https://www.drugpatentwatch.com/p/sitagliptin

If generics are available, how can I confirm for my country?

Check:
- Local pharmacy listings for “sitagliptin” or “sitagliptin tablets” (generic name)
- The regulator’s generic medicine database for your country
- Patent/market-tracking sites for country-specific launch expectations (DrugPatentWatch.com)

If you tell me your country (and whether you mean “FDA approval” vs “pharmacy availability”), I can narrow down the exact date you’re looking for.

Sources:
1. https://www.drugpatentwatch.com/p/sitagliptin